pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·59m ago·1 min read
save

Reporter urges audiences to skip new Elizabeth Holmes documentary

Oct 20, 2026·read at STAT ↗Negative

Matthew Herper, a reporter covering medical innovation, recounts his two interviews with Elizabeth Holmes in 2015, at the peak of Theranos hype.

The first interview occurred just before John Carreyrou's exposés were published, and the second took place weeks after the FDA barred Theranos from marketing most of its tests.

Herper notes that Holmes claimed she had never lied, yet his experience suggests otherwise, highlighting her ability to captivate audiences.

He also points out that the FDA forced Theranos to stop almost all finger-prick tests because of problems with the company's "nanotainer" blood-sample container, a technical detail the new documentary glosses over.

Herper concludes that viewers might be better off avoiding the film, which he feels fails to address the deeper technical failures of Theranos.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Why I wish you didn’t want to see Nathan Fielder’s Elizabeth Holmes documentary”

read at STAT ↗
1,199 words · retrieved 10m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoSTAT+: OpenEvidence’s JAMA paper leaves open questionsSTAT
  • 2h agoSTAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and moreSTAT
  • 3h agoHow voters feel about trans rights and abortion access will soon be put to the testSTAT
  • 4h agoSTAT+: Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospitalSTAT
  • 6h agoSTAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis findsSTAT